RADIANCE Continued Access Protocol

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 300 participants.

Also called NCT05017935

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05017935
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05017935. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-04 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RADIANCE Continued Access Protocol
Acronym
RADIANCE CAP
Condition
Hypertension
Condition
Hypertension, Resistant to Conventional Therapy
Condition
Vascular Diseases
Condition
Cardiovascular Diseases
Intervention (Device)
Renal Denervation
Lead sponsor
ReCor Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05017935
Content hash
009fe8b558e746df54574a837ecfa19c92b989aebf80b6d83bcbc4b59fe5bc10